SPONSOR
Thomas Jefferson University
Total Trials
11
Recruiting
11
Phases
Phase 3, Phase 2, Phase 1
Conditions studied: Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage 1 Breast Cancer AJCC v8Anatomic Stage 2 Breast Cancer AJCC v8Anatomic Stage 3 Breast Cancer AJCC v8Breast Ductal Carcinoma in SituInvasive Breast CarcinomaTriple Negative Breast CarcinomaSpinal Dural Arteriovenous FistulaLiver DiseasesPortal Hypertension
Thomas Jefferson University is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8, Anatomic Stage 2 Breast Cancer AJCC v8, Anatomic Stage 3 Breast Cancer AJCC v8.
The trial portfolio spans Phase 3, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Thomas Jefferson University
How many clinical trials has Thomas Jefferson University sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Thomas Jefferson University, of which 11 are actively recruiting participants. These trials cover conditions including Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8, Anatomic Stage 2 Breast Cancer AJCC v8. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Thomas Jefferson University research focus on?
Thomas Jefferson University clinical trials span Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8, Anatomic Stage 2 Breast Cancer AJCC v8, Anatomic Stage 3 Breast Cancer AJCC v8, Breast Ductal Carcinoma in Situ, and additional conditions. The research pipeline includes Phase 3, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Thomas Jefferson University clinical trial?
To participate in a Thomas Jefferson University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Thomas Jefferson University trials with current recruitment status updated daily.
Clinical Trials by Thomas Jefferson University
NCT04959474
Recruiting
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
Anatomic Stage 0 Breast Cancer AJCC v8
NCT07574645
Recruiting
Spinal Dural Arteriovenous Fistula International Data and Outcomes Registry
Spinal Dural Arteriovenous Fistula
NCT05470205 Phase 3
Recruiting
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
Liver Diseases
NCT04720456 Phase 2
Recruiting
SHAPE of Portal Hypertension in Children
Hypertension, Portal
NCT05031910
Recruiting
Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality
Head and Neck Squamous Cell Carcinoma
NCT07402018
Recruiting
Intra-aortic Balloon Counterpulsation (IABC) Compliance
Cardiogenic Shock
NCT07234968
Recruiting
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
Bladder Cancer
NCT07436351
Recruiting
ACT With CF Self-Help Toolkit
Cystic Fibrosis (CF)
NCT07501650 Phase 1
Recruiting
Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer
Head and Neck Cancer
NCT06419803
Recruiting
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
Gestational Diabetes
NCT07145801 Phase 2
Recruiting
Y-90 Treatment Response Using Transarterial Radioembolization
HCC
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology